Predictors for early mortality in patients with implantable cardiac defibrillator for heart failure with reduced ejection fraction

Implantable cardioverter defibrillators (ICD) are recommended in heart failure with reduced ejection fraction (HFrEF) patients to reduce arrhythmic deaths. This study aimed to identify risk factors associated with mortality within one-year following the ICD. The data from our hospital's electronic database system was extracted for patients who were implanted ICD secondary to HFrEF between 2009 and 2019. Overall, 1107 patients were included in the present analysis. Mortality rate at one-year following the device implantation was 4.7%. In multivariate analysis; age, atrial fibrillation, New York Heart Association classification >2, blood urea nitrogen, pro-brain natriuretic peptide and albumin independently predicted one year mortality

Keywords

Heart failure with reduced ejection fraction, Implantable cardiac defibrillator, Early mortality

Citation

Çinier Goksel, Hayıroglu Mert Ilker, Çınar Tufan, Pay Levent, Yumurtas Ahmet Çagdas, Tezen Ozan, Eren Semih, Kolak Zeynep, Çetin Tugba, Ozcan Serhan, Türkkan Ceyhan, Ozbilgin Nazmiye, Tekkesin Ahmet Ilker, Alper Ahmet Taha, Gürkan Kadir. Predictors for early mortality in patients with implantable cardiac defibrillator for heart failure with reduced ejection fraction. Indian Heart Journal. 2022 Apr; 74(2): 127-130

URI

https://imsear.searo.who.int/handle/123456789/220881

Collections

Indian Heart Journal

Full item page